ArticleQuantitative imaging in medicine and surgery2025
The association between volume reduction ratio and time after ultrasound-guided microwave ablation for benign thyroid nodules of different compositions.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ultrasound-guided microwave ablation (MWA) is effective in the treatment of benign thyroid nodules (BTNs); however, there are large individual differences in the degree of lesion absorption and shrinkage speed. Although the internal components of nodules are important influential factors, few studies have reported temporal changes in the volume reduction ratio (VRR) in BTNs with different compositions. Therefore, this study aimed to explore how the thyroid nodule VRR changes over time and determine when it increases most significantly for BTNs of different compositions after MWA. Methods: This is a retrospective study. We consecutively collected patients that received MWA for BTNs from July 2020 to June 2021, with 12 months of follow-up, and VRR >50% as effective treatment indicator. A generalized additive model was used to analyze temporal changes in the VRR in BTNs of different compositions, and a log-likelihood ratio test of the segmented regression model was used to determine a potential threshold. We evaluated the consistency of two operators in MWA of BTNs. Results: In total, 221 treatment-effective nodules (216 patients) were included, in which 21 were predominantly cystic, 61 were predominantly solid, and 139 were solid nodules. A non-linear relationship was detected between VRR and time. In predominantly cystic nodules, the VRR increased by 36% per month until 2.0 months and by 1.4% per month after 2.0 months. In predominantly solid nodules, the VRR increased by 30.6% per month until 2.3 months and by 0.7% per month after 2.3 months. In solid nodules, the VRR increased by 17.4% per month until 4.3 months and by 0.3% per month after 4.3 months. Intraclass correlation coefficient (ICC) was 0.839 (95% confidence interval: 0.773, 0.887), indicating good consistency between the two operators. Conclusions: The VRR after ultrasound-guided MWA for different components of BTNs was non-linearly related with follow-up time, and there was a threshold effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.